Previous studies have shown that OIP5 is highly expressed in various human malignant tumors, such as breast cancer [10], malignant glioma [21], liver cancer [14], and bladder cancer [22], and can cause corresponding immune responses in tumor patients. This evidence concerns the gene OIP5 and urinary bladder carcinoma.